Neural Responses and Dysphoria: Modulation by a Pharmacological Probe

NCT01101685 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Dysphoria

Interventions

DRUG: Escitalopram
DRUG: Placebo

Sponsor

University of Oxford

Collaborators

[object Object]
[object Object]
[object Object]